Influence of the terminal complement-complex on reperfusion injury, no-reflow and arrhythmias: a comparison between C6-competent and C6-deficient rabbits.

[1]  J. Schofer,et al.  Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. , 1994, European heart journal.

[2]  E. F. Smith,et al.  Reduction of myocardial reperfusion injury with human soluble complement receptor type 1 (BRL 55730). , 1993, European journal of pharmacology.

[3]  M. Weisfeldt,et al.  Evaluation of the Role of Polymorphonuclear Leukocytes on Contractile Function in Myocardial Reperfusion Injury Evidence for Plasma‐Mediated Leukocyte Activation , 1993, Circulation.

[4]  W. Dreyer,et al.  Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. , 1992, Circulation research.

[5]  B. Lucchesi,et al.  Effects of complement activation in the isolated heart. Role of the terminal complement components. , 1992, Circulation research.

[6]  G. D. Ross.  Complement receptor type 1. , 1992, Current topics in microbiology and immunology.

[7]  B. Morgan.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. , 1989, The Biochemical journal.

[8]  J. Downey,et al.  Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart. , 1989, Journal of molecular and cellular cardiology.

[9]  J. Downey,et al.  Progression of myocardial infarction in a collateral flow deficient species. , 1989, Japanese heart journal.

[10]  S. Bhakdi,et al.  Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes , 1989, The Journal of experimental medicine.

[11]  L. McManus,et al.  Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. , 1988, Circulation.

[12]  H. Müller-Eberhard,et al.  Molecular organization and function of the complement system. , 1988, Annual review of biochemistry.

[13]  J Tranum-Jensen,et al.  The subendocardial border zone during acute ischemia of the rabbit heart: an electrophysiologic, metabolic, and morphologic correlative study. , 1986, Circulation.

[14]  D. Mathey,et al.  Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. , 1986, Journal of immunology.

[15]  M. Entman,et al.  Selective Accumulation of the First Component of Complement and Leukocytes in Ischemic Canine Heart Muscle: A Possible Initiator of an Extra Myocardial Mechanism of Ischemic Injury , 1985, Circulation research.

[16]  R. Virmani,et al.  Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. , 1985, Circulation.

[17]  D. Hearse,et al.  Reperfusion-induced arrhythmias: mechanisms and prevention. , 1984, Journal of molecular and cellular cardiology.

[18]  L. McManus,et al.  Complement localization in ischemic baboon myocardium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[19]  C. Connelly,et al.  Movement of necrotic wavefront after coronary artery occlusion in rabbit. , 1982, The American journal of physiology.

[20]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.

[21]  M. Fishbein,et al.  The Relationship of Vascular Injury and Myocardial Hemorrhage to Necrosis After Reperfusion , 1980, Circulation.

[22]  R. Kloner,et al.  The no reflow phenomenon: a time-limiting factor for reperfusion after coronary occlusion? , 1980, The American journal of cardiology.

[23]  L. McManus,et al.  Complement localization and mediation of ischemic injury in baboon myocardium. , 1980, The Journal of clinical investigation.

[24]  P. Boor,et al.  A simple planimetric method for determination of left ventricular mass and necrotic myocardial mass in postmortem hearts. , 1977, American journal of clinical pathology.

[25]  P. Pairolero,et al.  Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. , 1975, The Journal of thoracic and cardiovascular surgery.

[26]  R. Kloner,et al.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog. , 1974, The Journal of clinical investigation.

[27]  R. O'rourke,et al.  Antibody-independent activation of human C1 after interaction with heart subcellular membranes. , 1973, Journal of immunology.

[28]  P. Ward,et al.  THE PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATS , 1971, The Journal of experimental medicine.